Equitable Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.3M Buy
92,927
+4,415
+5% +$489K 0.08% 198
2025
Q1
$9.92M Buy
88,512
+2,728
+3% +$306K 0.09% 187
2024
Q4
$7.92M Sell
85,784
-683
-0.8% -$63.1K 0.08% 211
2024
Q3
$7.25M Buy
86,467
+22,560
+35% +$1.89M 0.07% 216
2024
Q2
$4.38M Buy
63,907
+1,427
+2% +$97.9K 0.05% 288
2024
Q1
$4.58M Buy
62,480
+405
+0.7% +$29.7K 0.05% 258
2023
Q4
$5.03M Buy
62,075
+518
+0.8% +$42K 0.06% 225
2023
Q3
$4.61M Buy
61,557
+2,090
+4% +$157K 0.07% 211
2023
Q2
$4.58M Buy
59,467
+4,024
+7% +$310K 0.07% 204
2023
Q1
$4.6M Buy
55,443
+6,656
+14% +$552K 0.07% 186
2022
Q4
$4.19M Buy
48,787
+763
+2% +$65.5K 0.07% 178
2022
Q3
$2.96M Sell
48,024
-204
-0.4% -$12.6K 0.06% 212
2022
Q2
$2.98M Buy
48,228
+520
+1% +$32.1K 0.06% 207
2022
Q1
$2.84M Buy
47,708
+6,864
+17% +$408K 0.05% 227
2021
Q4
$2.97M Sell
40,844
-409
-1% -$29.7K 0.05% 223
2021
Q3
$2.88M Buy
41,253
+156
+0.4% +$10.9K 0.05% 215
2021
Q2
$2.83M Buy
41,097
+599
+1% +$41.2K 0.05% 209
2021
Q1
$2.62M Buy
40,498
+5,797
+17% +$375K 0.06% 200
2020
Q4
$2.02M Sell
34,701
-1,003
-3% -$58.4K 0.05% 220
2020
Q3
$2.26M Buy
35,704
+1,535
+4% +$97K 0.06% 188
2020
Q2
$2.63M Sell
34,169
-1,141
-3% -$87.8K 0.08% 160
2020
Q1
$2.64M Buy
35,310
+1,940
+6% +$145K 0.09% 133
2019
Q4
$2.17M Buy
+33,370
New +$2.17M 0.06% 179